StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Acro Biomedical's operating income for the twelve months ending Jun 30, 2026 was -$209.30K. For fiscal 2025 it was -$154.02K. The highest annual figure on record is $515.55K in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$154.02K–
FY2024Dec 31, 2024-$37.96K–
FY2023Dec 31, 2023-$8.80M–
FY2022Dec 31, 2022-$15.87M–
FY2021Dec 31, 2021-$7.69M–
FY2019Sep 30, 2019-$441.55K-185.6%
FY2018Sep 30, 2018$515.55K–
FY2017Sep 30, 2017-$2.25K-105.2%
FY2016Sep 30, 2016$43.43K–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026-$17.55K–
Q1 FY2026CQ1 2026Mar 31, 2026-$60.27K–
Q4 FY2025CQ4 2025Dec 31, 2025-$16.38K–
Q3 FY2025CQ3 2025Sep 30, 2025-$115.10K–
Q2 FY2025CQ2 2025Jun 30, 2025-$13.61K–
Q1 FY2025CQ1 2025Mar 31, 2025-$8.93K–
Q4 FY2024CQ4 2024Dec 31, 2024-$9.47K–
Q3 FY2024CQ3 2024Sep 30, 2024-$9.11K–
Q2 FY2024CQ2 2024Jun 30, 2024-$9.09K–
Q1 FY2024CQ1 2024Mar 31, 2024-$10.30K–
Q4 FY2023CQ4 2023Dec 31, 2023-$17.40K–
Q3 FY2023CQ3 2023Sep 30, 2023-$1.59M–
Q2 FY2023CQ2 2023Jun 30, 2023-$3.19M–
Q1 FY2023CQ1 2023Mar 31, 2023-$4.00M–
Q4 FY2022CQ4 2022Dec 31, 2022-$3.93M–
Q3 FY2022CQ3 2022Sep 30, 2022-$4.01M–
Q2 FY2022CQ2 2022Jun 30, 2022-$4.00M–
Q1 FY2022CQ1 2022Mar 31, 2022-$3.93M–
Q4 FY2021CQ4 2021Dec 31, 2021-$3.85M–
Q3 FY2021CQ3 2021Sep 30, 2021-$2.99M–
Q2 FY2021CQ2 2021Jun 30, 2021-$793.32K–
Q1 FY2021CQ1 2021Mar 31, 2021-$56.99K–
Q4 FY2019CQ3 2019Sep 30, 2019-$64.46K-140.0%
Q3 FY2019CQ2 2019Jun 30, 2019-$68.09K-138.6%
Q2 FY2019CQ1 2019Mar 31, 2019-$214.77K-319.1%
Q1 FY2019CQ4 2018Dec 31, 2018-$94.24K-217.5%
Q4 FY2018CQ3 2018Sep 30, 2018$161.09K+307.9%
Q3 FY2018CQ2 2018Jun 30, 2018$176.23K–
Q2 FY2018CQ1 2018Mar 31, 2018$98.01K–
Q1 FY2018CQ4 2017Dec 31, 2017$80.23K–
Q4 FY2017CQ3 2017Sep 30, 2017$39.50K-51.1%
Q3 FY2017CQ2 2017Jun 30, 2017-$11.89K–
Q2 FY2017CQ1 2017Mar 31, 2017-$22.44K–
Q1 FY2017CQ4 2016Dec 31, 2016-$7.41K–
Q4 FY2016CQ3 2016Sep 30, 2016$80.73K–
Q3 FY2016CQ2 2016Jun 30, 2016-$17.13K–

More Acro Biomedical figures

See a number that looks wrong?